Inventor

PERRON HERVE

FR37 patents

⚠️ This page may combine multiple inventors who share the name “PERRON HERVE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

PERRON HERVE

BIO MERIEUX

Cell lines and viral isolates associated with multiple sclerosis

Isolated nucleotide sequences associated with Multiple sclerosis

Detection of MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple sclerosis, by nucleic acid hybridization

Method for detecting and/or quantifying a gliotoxic factor

Process for the production of a viable cell culture infected by a multiple sclerosis-associated virus

Cytotoxic factor as is associated with multiple sclerosis, its detection and its quantification

Isolated nucleotide sequences associated with multiple sclerosis or rheumatoid arthritis and a process of detecting

Viral isolates associated with multiple sclerosis

MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple sclerosis, and biopolymer constituents thereof

Retrovirus agents MSRV1 and MSRV2 associated with multiple sclerosis

Multiple sclerosis related virus

Process and culture medium for the production of cells infected by a multiple sclerosis-associated virus

Cytotoxic factor as is associated with multiple sclerosis, its detection and its quantification

Polypeptide capable of reacting with antibodies of patients suffering from multiple sclerosis and uses

LTR region of MSRV-1 and the proteins it encodes, and probes and methods for detecting MSRV-1 retrovirus

Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes

Process and culture medium for the production of cells infected by a multiple sclerosis-associated virus

Process and culture medium for the production of cells infected by a multiple sclerosis-associated virus

Process for the production of a viable cell culture infected by a multiple sclerosis-associated virus

BIOMERIEUX SA

Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes

Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease

Method for detecting PrP using at least one positive charge and/or at least one glycosidic bond and a ligand other than a protein ligand

Composition for treating pathology associated with MSRV/HERV-W

Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes

Multiple sclerosis-associated retroviral (MSRV) nucleic acids corresponding to the Env region

Method of isolating cytotoxic heterocomplex associated with multiple sclerosis

GENEURO SA

Therapeutic use of specific ligand in MSRV associated diseases

Therapeutic use of specific ligand in MSRV associated diseases

Antiretroviral drug targeting human endogenous retrovirus

Therapeutic use of specific ligand in MSRV associated diseases

Compounds for treating the remyelination blockade in diseases associated with the expression of HERV-W envelope protein

BIOMERIEUX STELHYS

Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease

BERNARD CORINNE

Therapeutic use of specific ligand in MSRV associated diseases

AFSSA

Process for detecting PrPSC using an antibiotic from the family of aminoglycosides

UNIV CLAUDE BERNARD LYON AND B

Process for detecting PrP using a macrocyclic adjuvant ligand

PARANHOS-BACCALA GLAUCIA

Isolated multiple sclerosis (MS)-associated retrovirus (MSRV) nucleic acids corresponding to the gag region

CECILLON SEBASTIEN

Method for detecting aggregate-forming circulating protein forms using an agent for aggregating said forms and an agent for capturing formed aggregates